The Nutshell

» funding, genetics & genomics, NIH and cancer

Daily News Roundup

Most Recent

French President Emmanuel Macron awards millions of euros in research funding to climate scientists who will relocate from the U.S. and elsewhere to France.

0 Comments

image: Putative Gay Genes Identified, Questioned

Putative Gay Genes Identified, Questioned

By | December 7, 2017

A genomic interrogation of homosexuality turns up speculative links between genetic elements and sexual orientation, but researchers say the study is too small to be significant. 

6 Comments

Among this year’s winners are a geneticist who revealed how plants respond to shade and a group of physicists who mapped the universe’s background radiation.

1 Comment

The Centers for Medicare and Medicaid Services propose covering the test with Medicare. 

0 Comments

The approval of the Roundup ingredient follows an extensive debate amidst conflicting evidence over the health effects of the world’s most popular weed killer. 

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

An analysis of President Trump’s proposed $7.2 billion slash to the National Institutes of Health budget points to dire consequences for the development of novel drugs.

0 Comments

image: Man Receives First In Vivo Gene-Editing Therapy

Man Receives First In Vivo Gene-Editing Therapy

By | November 15, 2017

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

0 Comments

image: Cancer Researcher, Former AACR President Dies

Cancer Researcher, Former AACR President Dies

By | November 13, 2017

Donald Coffey, a longtime professor at Johns Hopkins University, discovered the nuclear matrix within cells and its role in DNA replication.

0 Comments

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

0 Comments

FreeShip